In this issue:

- The Patent-Antitrust Interface: Are There Any No-No's Today?

- The U.S. First-to-File Patent System Takes Effect March 16, 2013

- An Overview of the Key Substantive Changes Implemented by the Recently Enacted Amendments to the Leahy-Smith America Invents Act and Title 35

- Exelixis Revisited: Conflict in Determining Patent Term Adjustment

- A Major Change in Patent Term Adjustment Calculus on Appeal to the Federal Circuit: Steps Applicants May Need to Consider to Preserve Rights

- Understanding New Restrictions on Advertising GI Bill Benefits

- Federal Agencies Solicit Public Comments Regarding PAEs

- If You Don’t Want Your Registration Cancelled, Grant Your Opponent a Covenant Not to Sue

- The Rocket Docket Takes on Rocket Science

- Announcements And Reminders

An excerpt from "Federal Agencies Solicit Public Comments Regarding PAEs"

Policy makers in Washington, DC have been hearing about the problems created by patent assertion entities – PAEs or, to some, “patent trolls” – from a number of quarters over the past few years. PAEs are generally entities that acquire patents and patent families in order to enforce them in the marketplace. A critical difference between PAEs and other patent holders is that PAEs don’t generally make or sell products or services of their own, but simply license their patents to others. As a result, they are less susceptible to patent claims asserted by their targets and less concerned about discovery burdens than other parties in patent litigation.

Please see full newsletter below for more information.